Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency

Samira Achouitar, Jennifer L. Goldstein, Miski Mohamed, Stephanie Austin, Keri Boyette, Francoise M. Blanpain, Catherine W. Rehder, Priya S. Kishnani, Saskia B. Wortmann, Martin den Heijer, Dirk J. Lefeber, Ron A. Wevers, Deeksha S. Bali, Eva Morava-Kozicz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We found that the missense mutation p.Pro1205Leu in the PHKA2 gene is a common cause of hepatic phosphorylase-kinase deficiency in Dutch patients, suggesting a founder-effect. Most patients presented with isolated growth delay and diarrhea, prior to the occurrence of hepatomegaly, delaying diagnosis. Tetraglucoside excretion correlated with disease severity and was used to follow compliance. The clinical presentation and therapeutic requirements in the same mutation carriers were variable, and PhK deficiency necessitated tube-feeding in some children.

Original languageEnglish (US)
Pages (from-to)691-694
Number of pages4
JournalMolecular Genetics and Metabolism
Volume104
Issue number4
DOIs
StatePublished - Dec 1 2011
Externally publishedYes

Fingerprint

Phosphorylase Kinase
Liver
Genes
Founder Effect
Phenotype
Mutation
Hepatomegaly
Enteral Nutrition
Missense Mutation
Compliance
Diarrhea
Growth
Glycogen Storage Disease Type Ix
Therapeutics

Keywords

  • Diarrhea
  • Founder effect
  • Glycogen storage disease type IX
  • Hypoglycemia
  • Tube-feeding

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency. / Achouitar, Samira; Goldstein, Jennifer L.; Mohamed, Miski; Austin, Stephanie; Boyette, Keri; Blanpain, Francoise M.; Rehder, Catherine W.; Kishnani, Priya S.; Wortmann, Saskia B.; den Heijer, Martin; Lefeber, Dirk J.; Wevers, Ron A.; Bali, Deeksha S.; Morava-Kozicz, Eva.

In: Molecular Genetics and Metabolism, Vol. 104, No. 4, 01.12.2011, p. 691-694.

Research output: Contribution to journalArticle

Achouitar, S, Goldstein, JL, Mohamed, M, Austin, S, Boyette, K, Blanpain, FM, Rehder, CW, Kishnani, PS, Wortmann, SB, den Heijer, M, Lefeber, DJ, Wevers, RA, Bali, DS & Morava-Kozicz, E 2011, 'Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency', Molecular Genetics and Metabolism, vol. 104, no. 4, pp. 691-694. https://doi.org/10.1016/j.ymgme.2011.08.021
Achouitar, Samira ; Goldstein, Jennifer L. ; Mohamed, Miski ; Austin, Stephanie ; Boyette, Keri ; Blanpain, Francoise M. ; Rehder, Catherine W. ; Kishnani, Priya S. ; Wortmann, Saskia B. ; den Heijer, Martin ; Lefeber, Dirk J. ; Wevers, Ron A. ; Bali, Deeksha S. ; Morava-Kozicz, Eva. / Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency. In: Molecular Genetics and Metabolism. 2011 ; Vol. 104, No. 4. pp. 691-694.
@article{cce125a71a1a4fbcace30c1fd1bcede0,
title = "Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency",
abstract = "We found that the missense mutation p.Pro1205Leu in the PHKA2 gene is a common cause of hepatic phosphorylase-kinase deficiency in Dutch patients, suggesting a founder-effect. Most patients presented with isolated growth delay and diarrhea, prior to the occurrence of hepatomegaly, delaying diagnosis. Tetraglucoside excretion correlated with disease severity and was used to follow compliance. The clinical presentation and therapeutic requirements in the same mutation carriers were variable, and PhK deficiency necessitated tube-feeding in some children.",
keywords = "Diarrhea, Founder effect, Glycogen storage disease type IX, Hypoglycemia, Tube-feeding",
author = "Samira Achouitar and Goldstein, {Jennifer L.} and Miski Mohamed and Stephanie Austin and Keri Boyette and Blanpain, {Francoise M.} and Rehder, {Catherine W.} and Kishnani, {Priya S.} and Wortmann, {Saskia B.} and {den Heijer}, Martin and Lefeber, {Dirk J.} and Wevers, {Ron A.} and Bali, {Deeksha S.} and Eva Morava-Kozicz",
year = "2011",
month = "12",
day = "1",
doi = "10.1016/j.ymgme.2011.08.021",
language = "English (US)",
volume = "104",
pages = "691--694",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiency

AU - Achouitar, Samira

AU - Goldstein, Jennifer L.

AU - Mohamed, Miski

AU - Austin, Stephanie

AU - Boyette, Keri

AU - Blanpain, Francoise M.

AU - Rehder, Catherine W.

AU - Kishnani, Priya S.

AU - Wortmann, Saskia B.

AU - den Heijer, Martin

AU - Lefeber, Dirk J.

AU - Wevers, Ron A.

AU - Bali, Deeksha S.

AU - Morava-Kozicz, Eva

PY - 2011/12/1

Y1 - 2011/12/1

N2 - We found that the missense mutation p.Pro1205Leu in the PHKA2 gene is a common cause of hepatic phosphorylase-kinase deficiency in Dutch patients, suggesting a founder-effect. Most patients presented with isolated growth delay and diarrhea, prior to the occurrence of hepatomegaly, delaying diagnosis. Tetraglucoside excretion correlated with disease severity and was used to follow compliance. The clinical presentation and therapeutic requirements in the same mutation carriers were variable, and PhK deficiency necessitated tube-feeding in some children.

AB - We found that the missense mutation p.Pro1205Leu in the PHKA2 gene is a common cause of hepatic phosphorylase-kinase deficiency in Dutch patients, suggesting a founder-effect. Most patients presented with isolated growth delay and diarrhea, prior to the occurrence of hepatomegaly, delaying diagnosis. Tetraglucoside excretion correlated with disease severity and was used to follow compliance. The clinical presentation and therapeutic requirements in the same mutation carriers were variable, and PhK deficiency necessitated tube-feeding in some children.

KW - Diarrhea

KW - Founder effect

KW - Glycogen storage disease type IX

KW - Hypoglycemia

KW - Tube-feeding

UR - http://www.scopus.com/inward/record.url?scp=82255174963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82255174963&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2011.08.021

DO - 10.1016/j.ymgme.2011.08.021

M3 - Article

C2 - 21911307

AN - SCOPUS:82255174963

VL - 104

SP - 691

EP - 694

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 4

ER -